Successful repositioning of the subcutaneous implantable cardioverter-defibrillator lead to avoid inappropriate shock

J Arrhythm. 2023 Jan 4;39(1):74-77. doi: 10.1002/joa3.12805. eCollection 2023 Feb.

No abstract available

Keywords: Brugada syndrome; device; implantable cardioverter‐defibrillator; shock; ventricular fibrillation.